Section Arrow
Quote
CPHI.NYSE-M
- China Pharma Holdings Inc
Quotes are at least 15-min delayed:2026/09/28 12:01 EDT
Regular Hours
Last
 0.7256
-0.026 (-3.46%)
Day High 
0.7553 
Prev. Close
0.7516 
1-M High
0.999 
Volume 
61.91K 
Bid
0.711
Ask
0.7402
Day Low
0.711 
Open
0.7389 
1-M Low
0.6501 
Market Cap 
32.34M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.72 
20-SMA 0.78 
50-SMA 1.15 
52-W High 19.19 
52-W Low 0.3818 
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
-0.42/--
Enterprise Value
32.45M
Balance Sheet
Book Value Per Share
0.84
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
4.14M
Operating Revenue Per Share
0.18
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
HLNHaleon plc9.12-0.14-1.51%19.3PE
SCYXSCYNEXIS Inc4.6299+0.2399+5.46%-- 
HIMSHims & Hers Health28.6774-0.7426-2.52%-- 
VTRSViatris17.885+0.055+0.31%-- 
LFCRLifecore Biomedical6.5615+2.3615+56.23%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.